The Full Ratchet (TFR): Venture Capital and Startup Investing Demystified · Nick Moran
493. From Data Science to Drug Design: How AI Shifts Discovery, Target Validation, and Portfolio Construction (Jim Tananbaum)
·39 min·3 clips
Jim Tananbaum predicts the future where drugs are designed completely by AI, though he's unsure if it's three or ten years away.
As heard by us
A grounded look at biomarkers, prevention, and the slow pace of healthcare change.
Jim Tananbaum and Nick Moran keep this episode centered on healthcare investing, with a clear thread running through earlier detection, biomarkers, prevention, and the longer horizon of longevity.
Why you'd press play
For a VC lens on healthcare and life-sciences investing, with early detection, biomarkers, and the slow road to reimbursement.
Listen to the show on